MedPath

Effect of Formula on Growth of Infants From Overweight or Obese Mothers

Not Applicable
Completed
Conditions
Infant Nutrition
Registration Number
NCT00820833
Lead Sponsor
Société des Produits Nestlé (SPN)
Brief Summary

The purpose of this study is to determine whether infants, from overweight or obese mothers, fed a formula with proteins and calories different than a standard infant formula have a different growth

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
230
Inclusion Criteria
  • healthy newborn infant
  • birth weight between 2500g and 4800g
  • singleton birth
  • mother's BMI before pregnancy was between 26 and 25
  • for the breastfeeding group: mother has elected to exclusively breastfeed her baby from birth to at least 6 months of age
  • for the formula groups: mother has elected to exclusively formula feed her baby from 3 to 6 months of age
  • having obtained signed informed consent of legal representative
Exclusion Criteria
  • body weight smaller than 5th percentile for that gestational age
  • newborn whose mother has diabetes
  • newborn whose mother has a drug dependence during pregnancy
  • newborn currently participating in another trial

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
mean weight gain3 months
Secondary Outcome Measures
NameTimeMethod
blood test assessments; body composition, bone density9 months

Trial Locations

Locations (1)

Departamento de Medicina Interna, University de la Frontera

🇨🇱

Temuco, Chile

Departamento de Medicina Interna, University de la Frontera
🇨🇱Temuco, Chile

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.